{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:46:51Z","timestamp":1778856411246,"version":"3.51.4"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Journal Armed Forces India"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/s0377-1237(06)80055-9","type":"journal-article","created":{"date-parts":[[2011,6,10]],"date-time":"2011-06-10T10:17:57Z","timestamp":1307701077000},"page":"134-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of Suspected Monoclonal Gammopathies: Experience in a Tertiary Care Hospital"],"prefix":"10.1016","volume":"62","author":[{"given":"GS","family":"Chopra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PK","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DK","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0377-1237(06)80055-9_bib1","first-page":"79","article-title":"The laboratory investigation of monoclonal components","volume":"73","author":"Merlini","year":"1988","journal-title":"Haematologica"},{"key":"10.1016\/S0377-1237(06)80055-9_bib2","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0002-9343(81)90326-0","article-title":"The clinical aspects of biclonal gammopathies \u2014 Review of 57 cases","volume":"71","author":"Kyle","year":"1981","journal-title":"Am J Med"},{"key":"10.1016\/S0377-1237(06)80055-9_bib3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.5858\/1999-123-0106-GFCALE","article-title":"Guidelines for clinical and laboratory evaluation of patients with monoclonal gammopathies","volume":"123","author":"Keren","year":"1999","journal-title":"Arch Path Lab Med"},{"issue":"1","key":"10.1016\/S0377-1237(06)80055-9_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"issue":"6 Suppl 17","key":"10.1016\/S0377-1237(06)80055-9_bib5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/sonc.2002.34069","article-title":"Diagnosis of multiple myeloma","volume":"29","author":"Kyle","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/S0377-1237(06)80055-9_bib6","series-title":"Neoplastic diseases of the blood","first-page":"373","article-title":"Immunoglobulins and laboratrory recognition of monoclonal proteins","author":"Kyle","year":"1991"},{"key":"10.1016\/S0377-1237(06)80055-9_bib7","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0268-960X(89)90030-1","article-title":"Monoclonal gammopathies: new approaches to clinical problems in diagnosis and prognosis","volume":"3","author":"Greipp","year":"1989","journal-title":"Blood Rev"},{"key":"10.1016\/S0377-1237(06)80055-9_bib8","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1093\/clinchem\/34.11.2196","article-title":"Strategy to diagnose monoclonal gammopathies in serum: high resolution electrophoresis, immunofixation, and kappa\/lambda quantification","volume":"34","author":"Keren","year":"1988","journal-title":"Clin Chem"},{"key":"10.1016\/S0377-1237(06)80055-9_bib9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0889-8588(18)30348-4","article-title":"Diagnostic criteria of multiple myeloma","volume":"6","author":"Kyle","year":"1992","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/S0377-1237(06)80055-9_bib14","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1182\/blood.V85.2.448.448","article-title":"A new staging system for multiple myeloma based on the number of S-Phase plasma cells","volume":"85","author":"San Miguel","year":"1995","journal-title":"Blood"},{"issue":"2","key":"10.1016\/S0377-1237(06)80055-9_bib15","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1182\/blood.V85.2.448.448","article-title":"A new staging system for multiple myeloma based on the number of S-phase plasma cells","volume":"85","author":"San Miguel","year":"1995","journal-title":"Blood"},{"key":"10.1016\/S0377-1237(06)80055-9_bib16","series-title":"Myeloma","first-page":"243","article-title":"Laboratory investigations in myeloma","author":"Mehta","year":"2002"},{"key":"10.1016\/S0377-1237(06)80055-9_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1200\/JCO.1984.2.1.51","article-title":"Serum beta 2 - microglobulin in the initial staging and subsequent monitoring of monoclonal plasma cell disorders","volume":"2","author":"Garewal","year":"1984","journal-title":"J Clin Oncol"},{"key":"10.1016\/S0377-1237(06)80055-9_bib11","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000205322","article-title":"Multiple myeloma: beta-2 microglobulin is not a useful follow-parameter","volume":"82","author":"Boccadoro","year":"1989","journal-title":"Acta Haematol"},{"issue":"4","key":"10.1016\/S0377-1237(06)80055-9_bib12","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1365-2141.1990.tb07790.x","article-title":"Long-term prognostic value of serum beta 2 microglobulin in myelomatosis","volume":"75","author":"Cuzick","year":"1990","journal-title":"Br J Haematol"},{"key":"10.1016\/S0377-1237(06)80055-9_bib13","first-page":"765","article-title":"Immunoreactive interleukin - 6 and acute phase proteins as prognostic factors in multiple myeloma","volume":"85","author":"Pelliniemi","year":"1995","journal-title":"Finnish Leukemia Group Blood"}],"container-title":["Medical Journal Armed Forces India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0377123706800559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0377123706800559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T11:38:30Z","timestamp":1759837110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0377123706800559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0377123706800559"],"URL":"https:\/\/doi.org\/10.1016\/s0377-1237(06)80055-9","relation":{},"ISSN":["0377-1237"],"issn-type":[{"value":"0377-1237","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Suspected Monoclonal Gammopathies: Experience in a Tertiary Care Hospital","name":"articletitle","label":"Article Title"},{"value":"Medical Journal Armed Forces India","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0377-1237(06)80055-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Director General, Armed Forces Medical Services. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}